期刊文献+

前列腺癌尿液肿瘤标志物的研究进展

下载PDF
导出
摘要 前列腺癌是常见的男性恶性肿瘤.在世界范围内,前列腺癌已逐渐成为男性患者主要的医学问题.在欧美国家肿瘤相关性死亡原因中,前列腺癌排第二位[1].而近年来,随着人口老龄化、饮食结构改变及体检筛查的开展,我国前列腺癌的发病率呈现上升趋势,成为威胁我国男性健康的重要疾病.寻找特异性强、敏感性高的肿瘤标志物是前列腺癌早发现、早治疗的关键.
出处 《中国临床保健杂志》 CAS 2012年第6期664-667,共4页 Chinese Journal of Clinical Healthcare
  • 相关文献

参考文献5

  • 1Perner S,Demichelis F,Beroukhim R. TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer[J].Cancer Research,2006,(17):8337-8341.
  • 2Ouyang B,Bracken B,Burke B. A duplex quantitative polymerase chain reaction assay based on quantification of alpha-methylacyl-CoA racemase transcripts and prostate cancer antigen 3 in urine sediments improved diagnostic accuracy for prostate cancer[J].The Journal of Urology,2009,(06):2508-2513.doi:10.1016/j.juro.2009.01.110.
  • 3Jentzmik F,Stephan C,Miller K. Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours[J].European Urology,2010,(01):12-18.
  • 4Clarke RA,Zhao Z,Guo AY. New genomic structure for prostate cancer specific gene PCA3 within BMCC1:implications for prostate cancer detection and progression[J].PLoS One,2009,(03):e4995.
  • 5Ahmed H. Promoter methylation in prostate cancer and its application for the early detection of prostate cancer using serum and urine samples[J].Biomark Cancer,2010,(01):17-33.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部